Earnings Alerts

China Pacific Insurance (Group) Co. (601601) Earnings: YTD Life Premium Income Reaches 153.2B Yuan

  • China Pacific’s year-to-date (YTD) life premium income has reached 153.2 billion yuan.
  • YTD premium income for property and casualty insurance stands at 113 billion yuan.
  • Recent financial analysis shows 21 buy recommendations for China Pacific’s stock.
  • There are currently 3 hold recommendations for the stock.
  • No sell recommendations have been noted for China Pacific.

A look at China Pacific Insurance (Group) Co., Smart Scores

FactorScoreMagnitude
Value4
Dividend5
Growth4
Resilience3
Momentum5
OVERALL SMART SCORE4.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Pacific Insurance (Group) Company, Ltd. is positioned favorably for long-term growth, according to Smartkarma Smart Scores. With an impressive overall outlook indicated by its high scores in Dividend and Momentum, the company is likely to provide steady returns to investors. China Pacific Insurance (Group) Co. is recognized for its strong dividend offerings and positive market momentum, suggesting a promising future for shareholders.

As an integrated insurance services provider specializing in life and property insurance products, China Pacific Insurance (Group) Co. is well-positioned in the market. With above-average scores in Value and Growth, the company demonstrates potential for value appreciation and sustainable growth. While showing resilience amidst market challenges, China Pacific Insurance (Group) Co. stands out for its strong fundamentals and growth prospects, making it an attractive choice for investors seeking long-term opportunities.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars